198 related articles for article (PubMed ID: 30151986)
21. High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.
Shim BY; Lee MA; Byun JH; Roh SY; Song CW; Park JN; Lee JW; Min WS; Hong YS; Kim CC
Korean J Intern Med; 2004 Jun; 19(2):114-20. PubMed ID: 15366643
[TBL] [Abstract][Full Text] [Related]
22. Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma.
Stone A; Friedman DN; Kushner BH; Wolden S; Modak S; LaQuaglia MP; Costello J; Wu X; Cheung NK; Sklar CA
Pediatr Blood Cancer; 2019 Nov; 66(11):e27960. PubMed ID: 31407504
[TBL] [Abstract][Full Text] [Related]
23. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L
J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928
[TBL] [Abstract][Full Text] [Related]
24. Endocrine late effects from multi-modality treatment of neuroblastoma.
van Santen HM; de Kraker J; Vulsma T
Eur J Cancer; 2005 Aug; 41(12):1767-74. PubMed ID: 16039114
[TBL] [Abstract][Full Text] [Related]
25. Rapid-sequence tandem transplant for children with high-risk neuroblastoma.
Grupp SA; Stern JW; Bunin N; Nancarrow C; Adams R; Gorlin JB; Griffin G; Diller L
Med Pediatr Oncol; 2000 Dec; 35(6):696-700. PubMed ID: 11107149
[TBL] [Abstract][Full Text] [Related]
26. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
[TBL] [Abstract][Full Text] [Related]
27. A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.
Monnereau-Laborde S; Munzer C; Valteau-Couanet D; Ansoborlo S; Coze C; Chastagner P; Rubie H; Demeocq F; Stephan JL; Hartmann O; Perel Y
Pediatr Blood Cancer; 2011 Dec; 57(6):965-71. PubMed ID: 21744481
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation.
Trahair TN; Vowels MR; Johnston K; Cohn RJ; Russell SJ; Neville KA; Carroll S; Marshall GM
Bone Marrow Transplant; 2007 Oct; 40(8):741-6. PubMed ID: 17724446
[TBL] [Abstract][Full Text] [Related]
29. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors.
Broniscer A; Nicolaides TP; Dunkel IJ; Gardner SL; Johnson J; Allen JC; Sposto R; Finlay JL
Pediatr Blood Cancer; 2004 Mar; 42(3):261-7. PubMed ID: 14752864
[TBL] [Abstract][Full Text] [Related]
30. Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients.
Pasqualini C; Dufour C; Goma G; Raquin MA; Lapierre V; Valteau-Couanet D
Bone Marrow Transplant; 2016 Feb; 51(2):227-31. PubMed ID: 26524264
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
[TBL] [Abstract][Full Text] [Related]
32. Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols.
Saha A; Salley CG; Saigal P; Rolnitzky L; Goldberg J; Scott S; Olshefski R; Hukin J; Sands SA; Finlay J; Gardner SL
Pediatr Blood Cancer; 2014 Sep; 61(9):1644-52; quiz 1653-72. PubMed ID: 24789527
[TBL] [Abstract][Full Text] [Related]
33. Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.
Sokol E; Huang E; Pytel P; Cohn SL; Pinto N
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27663277
[No Abstract] [Full Text] [Related]
34. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study.
Kletzel M; Katzenstein HM; Haut PR; Yu AL; Morgan E; Reynolds M; Geissler G; Marymount MH; Liu D; Kalapurakal JA; Shore RM; Bardo DM; Schmoldt J; Rademaker AW; Cohn SL
J Clin Oncol; 2002 May; 20(9):2284-92. PubMed ID: 11980999
[TBL] [Abstract][Full Text] [Related]
35. Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma.
Ashraf K; Shaikh F; Gibson P; Baruchel S; Irwin MS
Pediatr Blood Cancer; 2013 Oct; 60(10):1636-41. PubMed ID: 23650219
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma.
Nève V; Foot AB; Michon J; Fourquet A; Zucker JM; Boulé M
Med Pediatr Oncol; 1999 Mar; 32(3):170-6. PubMed ID: 10064183
[TBL] [Abstract][Full Text] [Related]
37. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
[TBL] [Abstract][Full Text] [Related]
38. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
[TBL] [Abstract][Full Text] [Related]
39. Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium.
Kletzel M; Abella EM; Sandler ES; Williams LL; Ogden AK; Pollock BH; Wall DA
J Pediatr Hematol Oncol; 1998; 20(1):49-54. PubMed ID: 9482413
[TBL] [Abstract][Full Text] [Related]
40. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma.
Grupp SA; Stern JW; Bunin N; Nancarrow C; Ross AA; Mogul M; Adams R; Grier HE; Gorlin JB; Shamberger R; Marcus K; Neuberg D; Weinstein HJ; Diller L
J Clin Oncol; 2000 Jul; 18(13):2567-75. PubMed ID: 10893288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
